As a socially responsible investment firm, our mission is to contribute to the greater good and advance healthcare for all by making investments in life science and translational medicine innovations.
GeneSyn's investment strategy and portfolio are primarily focused on early-stage healthcare companies with strong intellectual property, with a specific interest in chronic disease management and preference for working with companies in the Greater Philadelphia area.
GeneSyn advises portfolio companies regarding optimization of their intellectual property strategy. From collaboration and development to licensing and commercialization, GeneSyn provides consulting to leverage intellectual property and maximize return on investment.
GeneSyn works with companies of various sizes and stages that are anchored in the healthcare industry. We are anxious to speak with you about your business to see if it is aligned with our mission and portfolio.
Please contact us today if you are seeking capital investment.